Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2016-04-30
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children
NCT01632046
A Study Comparing the Impact of Mini-exchange-room and Usual Care on Physical Activity and Quality of Life in Peritoneal Dialysis Patients
NCT01982344
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
NCT06443021
Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
NCT02044614
Transfer and Ultrafiltration In Peritoneal Dialysis
NCT02474719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To this end, the Peritoneal Equilibration Test (PET), which is routinely performed in children during a day hospital treatment to analyse peritoneal transport function, will be modified. Instead of a single 4 hour standard dwell, two double mini PET using the same type and total volume of dialysate and the same total dwell time (150min) will be performed in randomised sequence in a total of 15 stable pediatric PD patients treated in four different European pediatric dialysis centres. The conventional double mini PET consists of two identical cycles (fill volume 1 L/m², 75 min), the adapted one of a short, small cycle (0.6 mL/m² BSA, 30 min) followed by a long, large cycle (1.4 mL/m², 120 min). A total of 22 ml of blood will be drawn via a peripheral i.v. line, intraperitoneal pressure, in clinical routine controlled once during a PET, will be measured with each dwell.
The study analyses the time and volume dependent PD transport mechanisms. Patients included may benefit from the detailed analysis of peritoneal membrane function, allowing for optimisation of the individual PD prescription.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adapted double mini PET
PET = Peritoneal Equilibration Test, a test routinely performed to measure peritoneal transport rates of solutes and water in peritoneal dialysis patients. To this end the routinely administered dialysis fluid is infused into the peritoneal cavity. The test will be modified (adapted):
A short, small cycle (0.6 mL/m² BSA, 30 min) followed by a long, large cycle (1.4 mL/m², 120 min) will be performed in each patient and compared to a standard double mini PET.
Adapted double mini PET
The modified double mini PET mimics the treatment of adapted PD and thus allows its validation
Standard double mini PET
The Standard double mini PET consists of two identical cycles (fill volume 1 L/m², 75 min of dwell time)
Standard double mini PET
The standard double mini PET reflects the routine PD treatment in children and is used for standardized comparison
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted double mini PET
The modified double mini PET mimics the treatment of adapted PD and thus allows its validation
Standard double mini PET
The standard double mini PET reflects the routine PD treatment in children and is used for standardized comparison
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable PD
* Last peritonitis \> 4 weeks ago
Exclusion Criteria
* Hypoalbuminemia (serum albumin \< 25g/l)
* Relevant changes in dialysis regime and diet the three days preceding the study
* Hb \< 9 mg/dl
* Pregnancy
* History of repeated hernia or PD fluid leakage
* Intolerability of intraperitoneal pressure of up to 18 cm H2O at 1400ml/m²
* BSA in supine position (e.g. due to organomegaly)
* Any underlying diseases affecting the peritoneal membrane transport function (such as previous surgery with subsequent adhesions and fluid trapping, chronic bowl disease)
* Heart insufficiency
* Patients with catheter dysfunction, i.e. outflow problems (assessed by cycler alarms during the last 2 weeks)
5 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER
Great Ormond Street Hospital for Children NHS Foundation Trust
OTHER
Hôpital de Hautepierre
OTHER
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claus Peter Schmitt
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claus P Schmitt, MD
Role: PRINCIPAL_INVESTIGATOR
Center for Pediatric and Adolescent Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Pediatric and Adolescent Medicine
Heidelberg, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fischbach M, Schmitt CP, Shroff R, Zaloszyc A, Warady BA. Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription. Kidney Int. 2016 Apr;89(4):761-6. doi: 10.1016/j.kint.2015.12.032. Epub 2016 Jan 21.
Fischbach M, Zaloszyc A, Schaefer B, Schmitt CP. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol. 2014 Aug;29(8):1321-7. doi: 10.1007/s00467-013-2573-x. Epub 2013 Aug 2.
Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int. 2011 Jul-Aug;31(4):450-8. doi: 10.3747/pdi.2010.00146. Epub 2011 Mar 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-545/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.